New York, NY -- (SBWire) -- 04/18/2016 --Bile duct cancer (cholangiocarcinoma) is the presence of mutated epithelial cells that originate in the bile ducts. Though, cause of bile duct cancer (cholangiocarcinoma) is not certain. There are several factors that can enhance chances of developing bile duct cancer (cholangiocarcinoma). According to American Society of Clinical Oncology (ASCO), fewer than 3,000 people are affected with the disease annually in the U.S. and around 1,600 people are affected by the disease in the U.K., according to Cancer Research United Kingdom. Major indications of cholangiocarcinoma include abnormal liver function, abdominal pain, weight loss, generalized itching, discoloration of stool and urine etc. Causes of cholangiocarcinoma are not known but factors such as exposure to thorium dioxide, liver fluke infections and cholangitis have been known to increase the chances.
Bile duct cancer (cholangiocarcinoma) treatment market is driven by the technological advancement in healthcare sector and increase in prevalence of cancer patients across the globe. Also, enhanced emphasis of pharmaceutical companies on R&D to come up with potential treatment for bile duct cancer (cholangiocarcinoma). However, high cost associated with latest clinical trials and approvals act as a major barrier for global bile duct cancer (cholangiocarcinoma) treatment market.
Global bile duct cancer (cholangiocarcinoma) treatment market is classified on the basis of disease indication, by treatment type and geography.
Based on the disease indication, the global bile duct cancer (cholangiocarcinoma) treatment market is segmented into the following:
Intrahepatic bile duct cancer
Perihilar (hilar) bile duct cancers
Distal bile duct cancers
Based on the treatment type, the global bile duct cancer (cholangiocarcinoma) treatment market is segmented into the following:
Stent insertion
The PTC method
The ERCP method
Chemotherapy
5-fluorouracil
Gemcitabine
Cisplatin
Capecitabine
Oxaliplatin
Chemoradiation
Based on the region, the global bile duct cancer (cholangiocarcinoma) treatment market is segmented into the following:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Interested in report: Please follow the below the links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10094
Due of the availability of variety of chemotherapeutic agents for the bile duct cancer (cholangiocarcinoma) treatment, market for chemotherapeutic agents is expected to hold a greater share in global bile duct cancer (cholangiocarcinoma) treatment market. Innovative bile duct cancer (cholangiocarcinoma) treatment procedures are expected to launch into the market in the forecast period.
Depending on geographic region bile duct cancer (cholangiocarcinoma) treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounts maximum in global bile duct cancer (cholangiocarcinoma) market share. Market for bile duct cancer (cholangiocarcinoma) treatment is maximum in North America due to advanced healthcare facilities, adequate reimbursement policies and greater awareness towards health care. Europe and Asia-Pacific market is expected to register a healthy CAGR over the forecast period.
Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/10094
Some of the key players in bile duct cancer (cholangiocarcinoma) are Johnson & Johnson Services, Inc., ConMed Corporation, W. L. Gore & Associates, Inc., Dispomedica GmbH, InSitu Technologies Inc., Boston Scientific Corporation, Medtronic Plc, Pauldrach medical Handels- und Vertriebs GmbH, OptiMed Medizinische Instrumente GmbH among several others.
Follow us on LinkedIn: https://www.linkedin.com/company/persistence-market-research-&-consulting
Key points covered in the report
1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
North America
Europe
Asia
RoW
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
5) The report also provides porters five forces analysis of the market.-
About Persistence Market Research
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.
Global Industry Analysis on Bile Duct Cancer (Cholangiocarcinoma) Treatment Market, 2016 to 2022
Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Bile Duct Cancer (Cholangiocarcinoma) Treatment Market: Global Industry Analysis and Forecast 2016 - 2022".